NCT05950607 · RECRUITING

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

This trial tests a structured care program designed to help nursing home staff manage suspected infections in residents with dementia more carefully — using fewer antibiotics and avoiding unnecessary procedures. It is a pragmatic cluster trial, meaning whole facilities are randomized rather than individual patients. This is a Phase NA behavioral study, meaning it evaluates a care practice, not a drug or device. Details on the specific program components are limited in the source.

Eligibility criteria

Inclusion Criteria:
1. Age > 60
2. A diagnosis of dementia (any type)
3. Cognitive Functional Scale (CFS) > 1
4. NH length of stay >90 days
The CFS score categorizes cognitive impairment status based on data in the electronic health record into: 1. None, 2. Mild, 3. Moderate, and 4. Severe (advanced). For the primary outcome, the analysis will be restricted to residents with a CFS score of 3 or 4.
Exclusion Criteria:
1. Less than 60 years of age
2. Living in nursing home for less than 90 days
3. Does not have diagnosis of dementia
4. Does not meet CFS >1 score

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-01-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials